CA2595462A1 - Molecules de fusion hla et utilisations associees - Google Patents

Molecules de fusion hla et utilisations associees Download PDF

Info

Publication number
CA2595462A1
CA2595462A1 CA002595462A CA2595462A CA2595462A1 CA 2595462 A1 CA2595462 A1 CA 2595462A1 CA 002595462 A CA002595462 A CA 002595462A CA 2595462 A CA2595462 A CA 2595462A CA 2595462 A1 CA2595462 A1 CA 2595462A1
Authority
CA
Canada
Prior art keywords
fusion molecule
polynucleotide
hla
alpha
domain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002595462A
Other languages
English (en)
Inventor
Nalan Utku
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2595462A1 publication Critical patent/CA2595462A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002595462A 2005-01-21 2006-01-23 Molecules de fusion hla et utilisations associees Abandoned CA2595462A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US64599205P 2005-01-21 2005-01-21
US60/645,992 2005-01-21
PCT/EP2006/000560 WO2006077152A2 (fr) 2005-01-21 2006-01-23 Molecules de fusion hla et utilisations associees

Publications (1)

Publication Number Publication Date
CA2595462A1 true CA2595462A1 (fr) 2006-07-27

Family

ID=36601159

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002595462A Abandoned CA2595462A1 (fr) 2005-01-21 2006-01-23 Molecules de fusion hla et utilisations associees

Country Status (3)

Country Link
EP (1) EP1919949A2 (fr)
CA (1) CA2595462A1 (fr)
WO (1) WO2006077152A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013259598B2 (en) 2012-05-08 2018-10-04 Western University Of Health Sciences Standardized ex vivo platforms for the antigen-specific expansion of CD4+ T cell populations
CN103382224B (zh) * 2013-06-28 2015-03-18 英科隆生物技术（杭州）有限公司 含有四聚体形式的异源交联抗体的异源交联物及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5428598A (en) * 1997-08-19 1999-03-08 Mount Sinai School Of Medicine Of The City University Of New York, The Epitope-bearing major histocompatibility complex class II element/immunoglobulin chimeric molecules
JP2002504342A (ja) * 1998-02-19 2002-02-12 プレジデント アンド フェローズ オブ ハーバード カレッジ 一価ｍｈｃ結合ドメイン融合タンパク質および接合体、多価ｍｈｃ結合ドメイン融合タンパク質および接合体、ならびに多量体ｍｈｃ結合ドメイン融合タンパク質および接合体、そしてそれらのための使用
IL136511A0 (en) * 2000-06-01 2001-06-14 Gavish Galilee Bio Appl Ltd Genetically engineered mhc molecules
WO2003025000A2 (fr) * 2001-09-17 2003-03-27 Nalan Utku Peptides capables de moduler une reponse immunitaire

Also Published As

Publication number Publication date
EP1919949A2 (fr) 2008-05-14
WO2006077152A3 (fr) 2006-10-26
WO2006077152A2 (fr) 2006-07-27

Similar Documents

Publication Publication Date Title
AU2007248019B2 (en) Chimeric T cell receptors and related materials and methods of use
EP2917229B1 (fr) Anticorps et fragments de ceux-ci dirigés contre le domaine alpha-3 de protéine hla-g, procédés et moyens pour leur préparation et leurs utilisations
US6652858B2 (en) Use of OX-2 to suppress an immune response
JP2019530456A5 (fr)
CA2392477A1 (fr) Nouvelle molecule immunoregulatrice b7-h1,
JP3973167B2 (ja) リンパ球活性化抗原ｈｂ１５：免疫グロブリン上科の一種
AU9413898A (en) Receptor on the surface of activated T-cells: ACTS-4
US20030027358A1 (en) Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR)
JP2022522404A (ja) Ｔ細胞調節抗原提示ポリペプチド及びその使用方法
US7205386B2 (en) Truncated CD200
KR20180092947A (ko) 형질 전환 성장 인자-베타-반응성 폴리펩티드 및 이의 사용 방법
KR20220050168A (ko) Pd-1 작용제로 표적된 면역관용
JP2022522405A (ja) Ｔ細胞調節多量体ポリペプチド及びその使用方法
PT1600460E (pt) Utilização de uma substância activa que se liga a cd28 para a preparação de uma composição farmacêutica para o tratamento de b-cll
EP0977852A1 (fr) Famille d'immunoregulateur appeles recepteurs des leucocytes, ressemblant a l'immunoglobuline
AU2002223338A1 (en) Truncated CD200
JP2003523735A (ja) ヒトナチュラルキラー細胞によって媒介される天然細胞毒性に関連した新規トリガリングレセプターおよび同一の性質を有する抗体
CA2595462A1 (fr) Molecules de fusion hla et utilisations associees
US9096654B2 (en) Peptides capable of modulating the function of TIRC7
JPH08149981A (ja) Ｔ細胞α鎖による抗原特異的免疫制御の方法
Hecht et al. CGEN-15001, a Novel B7-like Protein, Controls Inflammation in a Translational Rheumatoid Arthritis (RA) Assay and Induces Treg Driven Long-Term Remission in an Autoimmune Disease Model
JPH09509044A (ja) 脳由来膜関連ｃｒｆ結合タンパク質
JP2005206478A (ja) 樹状細胞膜分子−ＩｇＦｃ融合ポリペプチドまたはそれに対する抗体を含む医薬組成物
AU772734B2 (en) Secreted and transmembrane polypeptides and nucleic acids encoding the same
CA2288307C (fr) Recepteur activateur nouveau entrant en jeu dans la cytoxicite naturelle induite par les cellules nk humaines et anticorps revelant sa presence

Legal Events

Date Code Title Description
FZDE Discontinued